To assess the role of tissue microbiota in metabolic diseases, Vaiomer uses nutritional animal models of metabolic diseases together with clinical samples from human. These animal models of type 2 diabetes, obesity and related disorders are housed in a modern SOPF animal facility (according to the Federation of European Laboratory Animal Science Association).
Example of mouse models of metabolic disorders used at Vaiomer:
Physiological studies and metabolic phenotyping, in particular in relation to glucose and lipid metabolism, are routinely performed with:
In addition to metabolic and physiological phenotyping, Vaiomer has a strong expertise in tissue and organ harvesting and preparation, in particular in relation to the high standard required for tissue microbiota analysis and high-scale omics technology. Analyzed tissues range from classical body fluid samples (blood, stools …) to more challenging tissues requiring our in-house specific expertise (intestinal mucosa separation, adipose tissues with specific fat pads dissection, brain, liver …).
Vaiomer forged a partnership with the company Physiogenex to provide an extended integrated service to nutrition and pharma industries. Physiogenex is a leading contract research organization providing validated nutritional animal models to evaluate diabetes, obesity, liver diseases (NASH), dyslipidemia, atherosclerosis and cardiovascular complications in rodents.
Need more information ? You are welcome to contact our experts
Interested in our services ? Submit your project